Medibank Private Ltd (MPL) - Net Assets

Latest as of December 2025: AU$2.34 Billion AUD ≈ $1.66 Billion USD

Based on the latest financial reports, Medibank Private Ltd (MPL) has net assets worth AU$2.34 Billion AUD (≈ $1.66 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.26 Billion ≈ $3.02 Billion USD) and total liabilities (AU$1.92 Billion ≈ $1.36 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MPL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$2.34 Billion
% of Total Assets	54.86%
Annual Growth Rate	6.15%
5-Year Change	22.56%
10-Year Change	-27.75%
Growth Volatility	25.31

Medibank Private Ltd - Net Assets Trend (2001–2025)

This chart illustrates how Medibank Private Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Medibank Private Ltd total assets for the complete picture of this company's asset base.

Annual Net Assets for Medibank Private Ltd (2001–2025)

The table below shows the annual net assets of Medibank Private Ltd from 2001 to 2025. For live valuation and market cap data, see how much is Medibank Private Ltd worth.

Year	Net Assets	Change
2025-06-30	AU$2.34 Billion ≈ $1.65 Billion	+1.34%
2024-06-30	AU$2.31 Billion ≈ $1.63 Billion	+10.59%
2023-06-30	AU$2.08 Billion ≈ $1.47 Billion	+7.13%
2022-06-30	AU$1.95 Billion ≈ $1.38 Billion	+2.07%
2021-06-30	AU$1.91 Billion ≈ $1.35 Billion	+6.02%
2020-06-30	AU$1.80 Billion ≈ $1.27 Billion	-49.85%
2019-06-30	AU$3.59 Billion ≈ $2.54 Billion	+2.39%
2018-06-30	AU$3.50 Billion ≈ $2.48 Billion	+2.14%
2017-06-30	AU$3.43 Billion ≈ $2.43 Billion	+6.04%
2016-06-30	AU$3.23 Billion ≈ $2.29 Billion	+4.26%
2015-06-30	AU$3.10 Billion ≈ $2.19 Billion	+5.76%
2014-06-30	AU$2.93 Billion ≈ $2.07 Billion	-4.71%
2013-06-30	AU$3.08 Billion ≈ $2.18 Billion	+90.05%
2012-06-30	AU$1.62 Billion ≈ $1.15 Billion	+2.14%
2011-06-30	AU$1.59 Billion ≈ $1.12 Billion	-7.84%
2010-06-30	AU$1.72 Billion ≈ $1.22 Billion	+19.42%
2009-06-30	AU$1.44 Billion ≈ $1.02 Billion	+8.23%
2008-06-30	AU$1.33 Billion ≈ $941.67 Million	+16.40%
2007-06-30	AU$1.14 Billion ≈ $809.01 Million	+34.80%
2006-06-30	AU$848.20 Million ≈ $600.16 Million	+29.83%
2005-06-30	AU$653.30 Million ≈ $462.25 Million	+49.33%
2004-06-30	AU$437.50 Million ≈ $309.56 Million	+11.41%
2003-06-30	AU$392.70 Million ≈ $277.86 Million	+2.70%
2002-06-30	AU$382.39 Million ≈ $270.57 Million	-31.45%
2001-06-30	AU$557.86 Million ≈ $394.72 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Medibank Private Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 298.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Retained Earnings	AU$2.22 Billion	95.19%
Common Stock	AU$85.00 Million	3.64%
Other Comprehensive Income	AU$27.40 Million	1.17%
Total Equity	AU$2.34 Billion	100.00%

Medibank Private Ltd Competitors by Market Cap

The table below lists competitors of Medibank Private Ltd ranked by their market capitalization.

Company	Market Cap
China Avionics Systems Co Ltd SHG:600372	$9.21 Billion
Universal Health Services Inc NYSE:UHS	$9.22 Billion
Addtech AB (publ.) ST:ADDT-B	$9.22 Billion
Alstom S.A. PA:ALO	$9.23 Billion
Arrowhead Pharmaceuticals Inc NASDAQ:ARWR	$9.19 Billion
Doosan KO:000150	$9.19 Billion
CITIC Securities Company Limited F:CI9	$9.19 Billion
LG Innotek Co Ltd KO:011070	$9.19 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medibank Private Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,305,700,000 to 2,335,900,000, a change of 30,200,000 (1.3%).
Net income of 500,800,000 contributed positively to equity growth.
Dividend payments of 473,700,000 reduced retained earnings.
Share repurchases of 6,400,000 reduced equity.
Other comprehensive income decreased equity by 124,900,000.
Other factors increased equity by 134,400,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$500.80 Million	+21.44%
Dividends Paid	AU$473.70 Million	-20.28%
Share Repurchases	AU$6.40 Million	-0.27%
Other Comprehensive Income	AU$-124.90 Million	-5.35%
Other Changes	AU$134.40 Million	+5.75%
Total Change	AU$-	1.31%

Book Value vs Market Value Analysis

This analysis compares Medibank Private Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.56x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 9.27x to 5.56x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-06-30	AU$0.51	AU$4.72	x
2014-06-30	AU$0.51	AU$4.72	x
2015-06-30	AU$0.52	AU$4.72	x
2016-06-30	AU$0.57	AU$4.72	x
2017-06-30	AU$0.62	AU$4.72	x
2018-06-30	AU$0.66	AU$4.72	x
2019-06-30	AU$0.70	AU$4.72	x
2020-06-30	AU$0.65	AU$4.72	x
2021-06-30	AU$0.69	AU$4.72	x
2022-06-30	AU$0.71	AU$4.72	x
2023-06-30	AU$0.76	AU$4.72	x
2024-06-30	AU$0.84	AU$4.72	x
2025-06-30	AU$0.85	AU$4.72	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medibank Private Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 21.44%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.85%
• Asset Turnover: 1.82x
• Equity Multiplier: 2.01x
Recent ROE (21.44%) is above the historical average (21.12%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	16.59%	3.88%	1.93x	2.22x	AU$92.43 Million
2014	9.38%	2.02%	2.18x	2.13x	AU$-8.59 Million
2015	19.79%	4.27%	2.13x	2.18x	AU$141.10 Million
2016	26.45%	6.13%	2.08x	2.07x	AU$259.73 Million
2017	26.14%	6.47%	2.01x	2.01x	AU$277.52 Million
2018	24.33%	6.77%	1.86x	1.94x	AU$262.18 Million
2019	23.70%	6.78%	1.86x	1.88x	AU$265.16 Million
2020	17.52%	4.61%	1.82x	2.08x	AU$135.22 Million
2021	23.15%	6.32%	1.78x	2.06x	AU$250.59 Million
2022	20.25%	5.55%	1.56x	2.34x	AU$199.34 Million
2023	24.52%	6.91%	1.69x	2.11x	AU$302.66 Million
2024	21.36%	6.14%	1.71x	2.03x	AU$261.93 Million
2025	21.44%	5.85%	1.82x	2.01x	AU$267.21 Million

Industry Comparison

This section compares Medibank Private Ltd's net assets metrics with peer companies in the Insurance - Specialty industry.

Industry Context

Industry: Insurance - Specialty
Average net assets among peers: $712,325,500
Average return on equity (ROE) among peers: 21.72%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Medibank Private Ltd (MPL)	AU$2.34 Billion	16.59%	0.82x	$9.20 Billion
Helia Group Ltd (HLI)	$1.08 Billion	21.43%	1.71x	$1.04 Billion
NIB Holdings Ltd (NHF)	$344.26 Million	22.02%	1.43x	$2.34 Billion

About Medibank Private Ltd

AU:MPL Australia Insurance - Specialty

Market Cap

$9.20 Billion

AU$13.00 Billion AUD

Market Cap Rank

#2375 Global

#48 in Australia

Share Price

AU$4.72

Change (1 day)

+0.64%

52-Week Range

AU$4.10 - AU$5.26

All Time High

AU$5.26